United States · FDA National Drug Code directory

AMLODIPINE BESYLATE 2.5 mg

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
72789-260_56d162c9-8f01-cab0-e063-6294a90ab853
Product NDC
72789-260
Form
TABLET
Composition / generic term
AMLODIPINE BESYLATE
Labeler
PD-Rx Pharmaceuticals, Inc.
Marketing category
ANDA
Marketing start / end (source format)
20211001
Source listing expiry
20271231

Source-listed ingredients

  • AMLODIPINE BESYLATE — 2.5 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

  • 30 TABLET in 1 BOTTLE, PLASTIC (72789-260-30) · 72789-260-30
  • 60 TABLET in 1 BOTTLE, PLASTIC (72789-260-60) · 72789-260-60
  • 90 TABLET in 1 BOTTLE, PLASTIC (72789-260-90) · 72789-260-90
  • 1000 TABLET in 1 BOTTLE, PLASTIC (72789-260-95) · 72789-260-95

Source and coverage

Open FDA National Drug Code directory →

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →
AMLODIPINE BESYLATE 2.5 mg — United States | Molindra Medicines